Skip to content

Leber Hereditary Optic Neuropathy (LHON) Historical Case Record Survey

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01892943
Enrollment
306
Registered
2013-07-08
Start date
2013-08-31
Completion date
2014-02-28
Last updated
2014-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Leber Hereditary Optic Neuropathy (LHON)

Brief summary

The objective of this survey is to establish the clinical course of vision loss and recovery in patients with a genetically confirmed diagnosis of Leber Hereditary Optic Neuropathy (LHON). Visual acuity changes over time from onset of symptoms and from visual acuity nadir will be the main endpoint analysed. The survey will collect historically documented visual acuity data for all patients at participating sites with a genetically confirmed diagnosis of LHON. No exclusion criteria apply. Patients are not required to attend the clinic for the survey. Data will be collected in a completely anonymous manner. Ethical approvals and data release agreements will be obtained as required by local regulations.

Interventions

None listed

Sponsors

European Vision Institute Clinical Research Network
CollaboratorNETWORK
Santhera Pharmaceuticals
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* patients with genetically confirmed diagnosis of LHON

Design outcomes

Primary

MeasureTime frameDescription
Visual acuityaverage 0 to 10 years (retrospective)The Entire duration of the disease patient by patient basis up to the date of completion of the Case Report Form (CRF).

Countries

Belgium, Denmark, France, Italy, Slovenia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026